Free Trial
NYSEAMERICAN:BDR

Blonder Tongue Laboratories (BDR) Stock Price, News & Analysis

Blonder Tongue Laboratories logo

About Blonder Tongue Laboratories Stock (NYSEAMERICAN:BDR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
190,300 shs
Average Volume
364,033 shs
Market Capitalization
$4.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BDR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Blonder Tongue Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BDR Stock News Headlines

Blonder Tongue Laboratories Inc.
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
How the colour of your tongue reveals your health
Abbott Laboratories BDR (ABTT34)
Forest Laboratories
See More Headlines

BDR Stock Analysis - Frequently Asked Questions

Blonder Tongue Laboratories, Inc. (NYSEAMERICAN:BDR) released its earnings results on Friday, May, 15th. The technology company reported ($0.21) earnings per share for the quarter. The technology company had revenue of $4.05 million for the quarter. Blonder Tongue Laboratories had a negative net margin of 8.71% and a negative trailing twelve-month return on equity of 56.15%.

Shares of BDR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Blonder Tongue Laboratories investors own include iBio (IBIO), VBI Vaccines (VBIV), Vaxart (VXRT), Nokia (NOK), Onconova Therapeutics (ONTX), Senseonics (SENS) and Agile Therapeutics (AGRX).

Company Calendar

Last Earnings
5/15/2020
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Radio & TV Communication Equipment
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:BDR
CIK
1000683
Employees
85
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.47 million
Net Margins
-8.71%
Pretax Margin
-8.62%
Return on Equity
-56.15%
Return on Assets
-12.11%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
1.35
Quick Ratio
0.63

Sales & Book Value

Annual Sales
$16.38 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.11 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
13,326,000
Free Float
5,337,000
Market Cap
$4.06 million
Optionable
Not Optionable
Beta
0.23
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSEAMERICAN:BDR) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners